Hepatitis C and hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue SUPPL.1, 1998, Pages

  Okuda, Kunio ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti hepatitis C virus antibodies; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DEVELOPING COUNTRY; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

EID: 0031739866     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb01896.x     Document Type: Article

References (37)

1. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 1983; 85: 439-62.
2. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
3. Kuo G, Choo Q-L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
4. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987; 47: 4967-72.
5. Iwama S, Ohnishi K, Nakajima Y et al. A clinical study of hepatocellular carcinoma (HCC) in relation to hepatitis B seromarkers. Implications of non-A, non-B hepatitis (NANB). Hepatology 1982; 2: 117 (abstract).
6. Kiyosawa K, Furuta S. Review of hepatitis C in Japan. J. Gastroenterol. Hepatol. 1991; 6: 383-91.
7. Colombo M, Kuo M, Choo QL et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; i: 1006-8.
8. Bruix J, Barrera JM, Calver X et al. Prevalence of antibodies of hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; i: 1004-6.
9. Okuda K. Hepatitis C virus and hepatocellular carcinoma. Okuda K, Tabor E, eds. Liver Cancer. London: Churchill Livingstone, 1997; 39-50.
10. Chen DS, Kuo GC, Sung L et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J. Infect. Dis. 1990; 162: 817-22.
11. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
12. Suou T, Ikuta Y, Hasegawa M, Kawasaki H. Prevalence of HCV antibodies in Yatsuka town of Simane Prefecture, Japan. Jpn. J. Gastroenterol. 1992; 89: 113-17.
13. Setoguchi Y, Yamamoto K, Ozaki I et al. Prevalence of chronic liver dieseases and anti-HCV antibodies in different districts of Saga, Japan. Gastroenterol. Jpn 1991; 26: 157-61.
14. Kiyosawa K, Tanaka E, Sodeyama T et al. Transmission of hepatitis C in an isolated area in Japan: Community acquired infection. Gastroenterology 1994; 106: 1596-602.
15. Seeff LB, NHLBI Study Group. Mortality and morbidity of transfusion-associated type C hepatitis: An NHLBI multicenter study. Hepatology 1995; 20: 204A (abstract).
16. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcome after transfusion-associated hepatitis C. N. Engl. J. Med. 1995; 332: 1463-6.
17. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321-4.
18. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347-53.
19. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-9.
20. Silini E, Bottelli R, Asti M et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study. Gastroenterology 1996; 111: 199-205.
21. Oka H, Kurioka N, Kim K et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
22. Colombo M, de Franchis R, Ninno ED et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med. 1991; 325: 675-80.
23. Ikeda K, Saitoh S, Koida I et al. A multivariate analysis of risk factors for hepatocellular carcinoma: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
24. Sato Y, Nakata K, Kato Y et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N. Engl. J. Med. 1993; 328: 1802-6.
25. Pateron D, Ganne N, Trinchet JC et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J. Hepatol. 1994; 20: 65-71.
26. Cottone M, Turri M, Caltagirone M et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: An 8-year prospective study by ultrasound and alpha-fetoprotein. J. Hepatol. 1994; 21: 1029-34.
27. Takada A, Takase S, Tsutsumi M. Alcohol and hepatic carcinogenesis. Yirmiya R, Taylor AN, eds. Alcohol, Immunity and Cancer. Boca Raton: CRC Press, 1993; 187-209.
28. Yamauchi M, Nakahara M, Maezawa Y et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am. J. Gastroenterol. 1993; 88: 39-43.
29. Kaklamani E, Trichopoulos D, Tzonou A et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 1974-6.
30. Chuang WL, Chang WY, Lu SN et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. Cancer 1992; 69: 2052-4.
31. Brechot C, Degos F, Lugassay C et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N. Engl. J. Med. 1985; 312: 270-6.
32. Blum H, Offensperger WB, Walter E et al. Latent hepatitis B virus infection with full-length viral genome in patients serologically immune to hepatitis B virus infection. Liver 1988; 8: 307-16.
33. Hagiwara H, Hayashi N, Mita E et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545-50.
34. Magrin S, Craxi A, Fablano C et al. Hepatitis C viremia in chronic liver disease: Relationship to interferon-α or corticosteroid treatment. Hepatology 1994; 19: 273-9.
35. Tarao K, Simizu A, Ohkawa S, Tamai S. Prediction of liver cancer development from cirrhosis. Type C cirrhosis. Jpn J. Intern. Med. 1995; 84: 1985-91.
36. Yano M, Kumada H, Kage M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
37. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol. 1995; 69: 3893-6.